コンパニオンアニマル用特殊医薬品の世界市場 2024-2028

概要

コンパニオンアニマル用特殊医薬品市場は2023-2028年に45億5,355万米ドル、予測期間中のCAGRは6.68%で成長すると予測されます。

当レポートでは、コンパニオンアニマル用特殊医薬品市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、ペットの人間化の進展、疾病予防やペット保険に対する意識の高まり、コンパニオンアニマル集団の高齢化などが牽引しています。

当レポートでは、コンパニオンアニマル向け特殊医薬品の充実が、今後数年間のコンパニオンアニマル用特殊医薬品市場成長を牽引する主要因の一つであると指摘しています。また、コンパニオンアニマル用特殊医薬品市場における企業合併・買収 (M&A) 増加や、コンパニオンアニマルの肥満症の拡大が、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• コンパニオンアニマル用特殊医薬品の世界市場 2018-2022
• 流通チャネル別セグメント分析 2018-2022
• 製品別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：流通チャネル別

• 市場セグメント
• 比較：流通チャネル別
• 動物病院：市場規模と予測 2023-2028
• ペットケアクリニック：市場規模と予測 2023-2028
• 薬局：市場規模と予測 2023-2028
• 市場機会：流通チャネル別

第7章 市場セグメンテーション：製品別

• 市場セグメント
• 比較：製品別
• ワクチン：市場規模と予測 2023-2028
• 抗生物質：市場規模と予測 2023-2028
• 寄生虫駆除剤：市場規模と予測 2023-2028
• 飼料添加物：市場規模と予測 2023-2028
• その他：市場規模と予測 2023-2028
• 市場機会：製品別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• 日本：市場規模と予測 2023-2028
• 市場機会：地域別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Bayer AG
• Beaphar Beheer BV
• Bimeda Holdings Ltd.
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Dechra Pharmaceuticals Plc
• Elanco Animal Health Inc.
• LABORATORIOS CALIER S.A
• Mars Inc.
• Merck and Co. Inc.
• Neogen Corp.
• Norbrook Laboratories Ltd.
• Vetoquinol SA
• Virbac Group
• Zoetis Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market by Geography
• Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits6: Executive Summary - Chart on Market Segmentation by Product
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global companion animal specialty drugs market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%)
• Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Distribution Channel
• Exhibits33: Data Table on Comparison by Distribution Channel
• Exhibits34: Chart on Veterinary hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Veterinary hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Veterinary hospitals - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Veterinary hospitals - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Pet care clinics - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Pet care clinics - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Pet care clinics - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Pet care clinics - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Pharmacy stores - Market size and forecast 2023-2028 ($ million)
• Exhibits43: Data Table on Pharmacy stores - Market size and forecast 2023-2028 ($ million)
• Exhibits44: Chart on Pharmacy stores - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Pharmacy stores - Year-over-year growth 2023-2028 (%)
• Exhibits46: Market opportunity by Distribution Channel ($ million)
• Exhibits47: Data Table on Market opportunity by Distribution Channel ($ million)
• Exhibits48: Chart on Product - Market share 2023-2028 (%)
• Exhibits49: Data Table on Product - Market share 2023-2028 (%)
• Exhibits50: Chart on Comparison by Product
• Exhibits51: Data Table on Comparison by Product
• Exhibits52: Chart on Vaccines - Market size and forecast 2023-2028 ($ million)
• Exhibits53: Data Table on Vaccines - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Antibiotics - Market size and forecast 2023-2028 ($ million)
• Exhibits57: Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)
• Exhibits60: Chart on Parasiticides - Market size and forecast 2023-2028 ($ million)
• Exhibits61: Data Table on Parasiticides - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Chart on Parasiticides - Year-over-year growth 2023-2028 (%)
• Exhibits63: Data Table on Parasiticides - Year-over-year growth 2023-2028 (%)
• Exhibits64: Chart on Feed additives - Market size and forecast 2023-2028 ($ million)
• Exhibits65: Data Table on Feed additives - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Chart on Feed additives - Year-over-year growth 2023-2028 (%)
• Exhibits67: Data Table on Feed additives - Year-over-year growth 2023-2028 (%)
• Exhibits68: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits69: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits70: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits71: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits72: Market opportunity by Product ($ million)
• Exhibits73: Data Table on Market opportunity by Product ($ million)
• Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits75: Chart on Market share by geography 2023-2028 (%)
• Exhibits76: Data Table on Market share by geography 2023-2028 (%)
• Exhibits77: Chart on Geographic comparison
• Exhibits78: Data Table on Geographic comparison
• Exhibits79: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits88: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits96: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits100: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits101: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits107: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits108: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits109: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits110: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits111: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits112: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits113: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits114: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits115: Market opportunity by geography ($ million)
• Exhibits116: Data Tables on Market opportunity by geography ($ million)
• Exhibits117: Impact of drivers and challenges in 2023 and 2028
• Exhibits118: Overview on Criticality of inputs and Factors of differentiation
• Exhibits119: Overview on factors of disruption
• Exhibits120: Impact of key risks on business
• Exhibits121: Vendors covered
• Exhibits122: Matrix on vendor position and classification
• Exhibits123: Bayer AG - Overview
• Exhibits124: Bayer AG - Business segments
• Exhibits125: Bayer AG - Key news
• Exhibits126: Bayer AG - Key offerings
• Exhibits127: Bayer AG - Segment focus
• Exhibits128: Beaphar Beheer BV - Overview
• Exhibits129: Beaphar Beheer BV - Product / Service
• Exhibits130: Beaphar Beheer BV - Key offerings
• Exhibits131: Bimeda Holdings Ltd. - Overview
• Exhibits132: Bimeda Holdings Ltd. - Product / Service
• Exhibits133: Bimeda Holdings Ltd. - Key offerings
• Exhibits134: Boehringer Ingelheim International GmbH - Overview
• Exhibits135: Boehringer Ingelheim International GmbH - Business segments
• Exhibits136: Boehringer Ingelheim International GmbH - Key news
• Exhibits137: Boehringer Ingelheim International GmbH - Key offerings
• Exhibits138: Boehringer Ingelheim International GmbH - Segment focus
• Exhibits139: Ceva Sante Animale - Overview
• Exhibits140: Ceva Sante Animale - Product / Service
• Exhibits141: Ceva Sante Animale - Key offerings
• Exhibits142: Dechra Pharmaceuticals Plc - Overview
• Exhibits143: Dechra Pharmaceuticals Plc - Business segments
• Exhibits144: Dechra Pharmaceuticals Plc - Key offerings
• Exhibits145: Dechra Pharmaceuticals Plc - Segment focus
• Exhibits146: Elanco Animal Health Inc. - Overview
• Exhibits147: Elanco Animal Health Inc. - Product / Service
• Exhibits148: Elanco Animal Health Inc. - Key offerings
• Exhibits149: LABORATORIOS CALIER S.A - Overview
• Exhibits150: LABORATORIOS CALIER S.A - Product / Service
• Exhibits151: LABORATORIOS CALIER S.A - Key offerings
• Exhibits152: Mars Inc. - Overview
• Exhibits153: Mars Inc. - Product / Service
• Exhibits154: Mars Inc. - Key news
• Exhibits155: Mars Inc. - Key offerings
• Exhibits156: Merck and Co. Inc. - Overview
• Exhibits157: Merck and Co. Inc. - Business segments
• Exhibits158: Merck and Co. Inc. - Key news
• Exhibits159: Merck and Co. Inc. - Key offerings
• Exhibits160: Merck and Co. Inc. - Segment focus
• Exhibits161: Neogen Corp. - Overview
• Exhibits162: Neogen Corp. - Business segments
• Exhibits163: Neogen Corp. - Key news
• Exhibits164: Neogen Corp. - Key offerings
• Exhibits165: Neogen Corp. - Segment focus
• Exhibits166: Norbrook Laboratories Ltd. - Overview
• Exhibits167: Norbrook Laboratories Ltd. - Product / Service
• Exhibits168: Norbrook Laboratories Ltd. - Key offerings
• Exhibits169: Vetoquinol SA - Overview
• Exhibits170: Vetoquinol SA - Business segments
• Exhibits171: Vetoquinol SA - Key news
• Exhibits172: Vetoquinol SA - Key offerings
• Exhibits173: Vetoquinol SA - Segment focus
• Exhibits174: Virbac Group - Overview
• Exhibits175: Virbac Group - Business segments
• Exhibits176: Virbac Group - Key news
• Exhibits177: Virbac Group - Key offerings
• Exhibits178: Virbac Group - Segment focus
• Exhibits179: Zoetis Inc. - Overview
• Exhibits180: Zoetis Inc. - Business segments
• Exhibits181: Zoetis Inc. - Key news
• Exhibits182: Zoetis Inc. - Key offerings
• Exhibits183: Zoetis Inc. - Segment focus
• Exhibits184: Inclusions checklist
• Exhibits185: Exclusions checklist
• Exhibits186: Currency conversion rates for US$
• Exhibits187: Research methodology
• Exhibits188: Validation techniques employed for market sizing
• Exhibits189: Information sources
• Exhibits190: List of abbreviations

Abstract

The companion animal specialty drugs market is forecasted to grow by USD 4553.55 mn during 2023-2028, accelerating at a CAGR of 6.68% during the forecast period. The report on the companion animal specialty drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in pet humanization, rising awareness about disease prevention and pet insurance, and rise in aging companion animal population.

Technavio's companion animal specialty drugs market is segmented as below:

By Distribution Channel

• Veterinary hospitals
• Pet care clinics
• Pharmacy stores

By Product

• Vaccines
• Antibiotics
• Parasiticides
• Feed additives
• Others

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the enhanced companion animal specialty drug offerings as one of the prime reasons driving the companion animal specialty drugs market growth during the next few years. Also, increase in m and a in the animal companion specialty drugs market and rising obesity in companion animals will lead to sizable demand in the market.

The report on the companion animal specialty drugs market covers the following areas:

• Companion animal specialty drugs market sizing
• Companion animal specialty drugs market forecast
• Companion animal specialty drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading companion animal specialty drugs market vendors that include Bayer AG, Beaphar Beheer BV, Bimeda Holdings Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Kyoritsuseiyaku Corp., LABORATORIOS CALIER S.A, Mars Inc., Merck and Co. Inc., Neogen Corp., Norbrook Laboratories Ltd., Tianjin ringpu bio-technology Co. Ltd., Vetoquinol SA, Virbac Group, Zenex Animal Health India Private Ltd., Zoetis Inc., and Orion Corp.. Also, the companion animal specialty drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market by Geography
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global companion animal specialty drugs market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global companion animal specialty drugs market 2018 - 2022 ($ million)
• 4.2 Distribution Channel Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• 4.3 Product Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

• 6.1 Market segments
• Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
• 6.2 Comparison by Distribution Channel
• Exhibit 32: Chart on Comparison by Distribution Channel
• Exhibit 33: Data Table on Comparison by Distribution Channel
• 6.3 Veterinary hospitals - Market size and forecast 2023-2028
• Exhibit 34: Chart on Veterinary hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Veterinary hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Veterinary hospitals - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Veterinary hospitals - Year-over-year growth 2023-2028 (%)
• 6.4 Pet care clinics - Market size and forecast 2023-2028
• Exhibit 38: Chart on Pet care clinics - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Pet care clinics - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Pet care clinics - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Pet care clinics - Year-over-year growth 2023-2028 (%)
• 6.5 Pharmacy stores - Market size and forecast 2023-2028
• Exhibit 42: Chart on Pharmacy stores - Market size and forecast 2023-2028 ($ million)
• Exhibit 43: Data Table on Pharmacy stores - Market size and forecast 2023-2028 ($ million)
• Exhibit 44: Chart on Pharmacy stores - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Pharmacy stores - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by Distribution Channel
• Exhibit 46: Market opportunity by Distribution Channel ($ million)
• Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Product

• 7.1 Market segments
• Exhibit 48: Chart on Product - Market share 2023-2028 (%)
• Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
• 7.2 Comparison by Product
• Exhibit 50: Chart on Comparison by Product
• Exhibit 51: Data Table on Comparison by Product
• 7.3 Vaccines - Market size and forecast 2023-2028
• Exhibit 52: Chart on Vaccines - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Vaccines - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
• 7.4 Antibiotics - Market size and forecast 2023-2028
• Exhibit 56: Chart on Antibiotics - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)
• 7.5 Parasiticides - Market size and forecast 2023-2028
• Exhibit 60: Chart on Parasiticides - Market size and forecast 2023-2028 ($ million)
• Exhibit 61: Data Table on Parasiticides - Market size and forecast 2023-2028 ($ million)
• Exhibit 62: Chart on Parasiticides - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Parasiticides - Year-over-year growth 2023-2028 (%)
• 7.6 Feed additives - Market size and forecast 2023-2028
• Exhibit 64: Chart on Feed additives - Market size and forecast 2023-2028 ($ million)
• Exhibit 65: Data Table on Feed additives - Market size and forecast 2023-2028 ($ million)
• Exhibit 66: Chart on Feed additives - Year-over-year growth 2023-2028 (%)
• Exhibit 67: Data Table on Feed additives - Year-over-year growth 2023-2028 (%)
• 7.7 Others - Market size and forecast 2023-2028
• Exhibit 68: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 69: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 70: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 71: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 7.8 Market opportunity by Product
• Exhibit 72: Market opportunity by Product ($ million)
• Exhibit 73: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 75: Chart on Market share by geography 2023-2028 (%)
• Exhibit 76: Data Table on Market share by geography 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 77: Chart on Geographic comparison
• Exhibit 78: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 UK - Market size and forecast 2023-2028
• Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.10 China - Market size and forecast 2023-2028
• Exhibit 107: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 108: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 109: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 110: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
• Exhibit 111: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 112: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 113: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 114: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity by geography
• Exhibit 115: Market opportunity by geography ($ million)
• Exhibit 116: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 117: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 119: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 120: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 121: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 122: Matrix on vendor position and classification
• 12.3 Bayer AG
• Exhibit 123: Bayer AG - Overview
• Exhibit 124: Bayer AG - Business segments
• Exhibit 125: Bayer AG - Key news
• Exhibit 126: Bayer AG - Key offerings
• Exhibit 127: Bayer AG - Segment focus
• 12.4 Beaphar Beheer BV
• Exhibit 128: Beaphar Beheer BV - Overview
• Exhibit 129: Beaphar Beheer BV - Product / Service
• Exhibit 130: Beaphar Beheer BV - Key offerings
• 12.5 Bimeda Holdings Ltd.
• Exhibit 131: Bimeda Holdings Ltd. - Overview
• Exhibit 132: Bimeda Holdings Ltd. - Product / Service
• Exhibit 133: Bimeda Holdings Ltd. - Key offerings
• 12.6 Boehringer Ingelheim International GmbH
• Exhibit 134: Boehringer Ingelheim International GmbH - Overview
• Exhibit 135: Boehringer Ingelheim International GmbH - Business segments
• Exhibit 136: Boehringer Ingelheim International GmbH - Key news
• Exhibit 137: Boehringer Ingelheim International GmbH - Key offerings
• Exhibit 138: Boehringer Ingelheim International GmbH - Segment focus
• 12.7 Ceva Sante Animale
• Exhibit 139: Ceva Sante Animale - Overview
• Exhibit 140: Ceva Sante Animale - Product / Service
• Exhibit 141: Ceva Sante Animale - Key offerings
• 12.8 Dechra Pharmaceuticals Plc
• Exhibit 142: Dechra Pharmaceuticals Plc - Overview
• Exhibit 143: Dechra Pharmaceuticals Plc - Business segments
• Exhibit 144: Dechra Pharmaceuticals Plc - Key offerings
• Exhibit 145: Dechra Pharmaceuticals Plc - Segment focus
• 12.9 Elanco Animal Health Inc.
• Exhibit 146: Elanco Animal Health Inc. - Overview
• Exhibit 147: Elanco Animal Health Inc. - Product / Service
• Exhibit 148: Elanco Animal Health Inc. - Key offerings
• 12.10 LABORATORIOS CALIER S.A
• Exhibit 149: LABORATORIOS CALIER S.A - Overview
• Exhibit 150: LABORATORIOS CALIER S.A - Product / Service
• Exhibit 151: LABORATORIOS CALIER S.A - Key offerings
• 12.11 Mars Inc.
• Exhibit 152: Mars Inc. - Overview
• Exhibit 153: Mars Inc. - Product / Service
• Exhibit 154: Mars Inc. - Key news
• Exhibit 155: Mars Inc. - Key offerings
• 12.12 Merck and Co. Inc.
• Exhibit 156: Merck and Co. Inc. - Overview
• Exhibit 157: Merck and Co. Inc. - Business segments
• Exhibit 158: Merck and Co. Inc. - Key news
• Exhibit 159: Merck and Co. Inc. - Key offerings
• Exhibit 160: Merck and Co. Inc. - Segment focus
• 12.13 Neogen Corp.
• Exhibit 161: Neogen Corp. - Overview
• Exhibit 162: Neogen Corp. - Business segments
• Exhibit 163: Neogen Corp. - Key news
• Exhibit 164: Neogen Corp. - Key offerings
• Exhibit 165: Neogen Corp. - Segment focus
• 12.14 Norbrook Laboratories Ltd.
• Exhibit 166: Norbrook Laboratories Ltd. - Overview
• Exhibit 167: Norbrook Laboratories Ltd. - Product / Service
• Exhibit 168: Norbrook Laboratories Ltd. - Key offerings
• 12.15 Vetoquinol SA
• Exhibit 169: Vetoquinol SA - Overview
• Exhibit 170: Vetoquinol SA - Business segments
• Exhibit 171: Vetoquinol SA - Key news
• Exhibit 172: Vetoquinol SA - Key offerings
• Exhibit 173: Vetoquinol SA - Segment focus
• 12.16 Virbac Group
• Exhibit 174: Virbac Group - Overview
• Exhibit 175: Virbac Group - Business segments
• Exhibit 176: Virbac Group - Key news
• Exhibit 177: Virbac Group - Key offerings
• Exhibit 178: Virbac Group - Segment focus
• 12.17 Zoetis Inc.
• Exhibit 179: Zoetis Inc. - Overview
• Exhibit 180: Zoetis Inc. - Business segments
• Exhibit 181: Zoetis Inc. - Key news
• Exhibit 182: Zoetis Inc. - Key offerings
• Exhibit 183: Zoetis Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 184: Inclusions checklist
• Exhibit 185: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 186: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 187: Research methodology
• Exhibit 188: Validation techniques employed for market sizing
• Exhibit 189: Information sources
• 13.5 List of abbreviations
• Exhibit 190: List of abbreviations